 |
 |
| Periowave, designed as an adjunctive therapy for the treatment of chronic periodontitis, is available in Canada and select countries in the European Union. It is currently under review for premarket approval by the US FDA. Credit: Ondine Biomedical. |
| © 2024 SPIE Europe |
|
